ReviewNature reviews. Clinical oncology2012

The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach.

Jan J Cornelissen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.